Literature DB >> 34524626

Effects of FW2 Nanoparticles Toxicity in a New In Vitro Pulmonary Vascular Cells Model Mimicking Endothelial Dysfunction.

J Deweirdt1,2, T Ducret1,2, J-F Quignard1,2, V Freund-Michel1,2, S Lacomme3, E Gontier3, B Muller1,2, R Marthan1,2,4, C Guibert1,2, I Baudrimont5,6.   

Abstract

Several epidemiological studies have revealed the involvement of nanoparticles (NPs) in respiratory and cardiovascular mortality. In this work, the focus will be on the effect of manufactured carbon black NPs for risk assessment of consumers and workers, as human exposure is likely to increase. Since the pulmonary circulation could be one of the primary targets of inhaled NPs, patients suffering from pulmonary hypertension (PH) could be a population at risk. To compare the toxic effect of carbon black NPs in the pulmonary circulation under physiologic and pathological conditions, we developed a new in vitro model mimicking the endothelial dysfunction and vascular dynamics observed in vascular pathology such as PH. Human pulmonary artery endothelial cells were cultured under physiological conditions (static and normoxia 21% O2) or under pathological conditions (20% cycle stretch and hypoxia 1% O2). Then, cells were treated for 4 or 6 h with carbon black FW2 NPs from 5 to 10 µg/cm2. Different endpoints were studied: (i) NPs internalization by transmission electronic microscopy; (ii) oxidative stress by CM-H2DCFDA probe and electron paramagnetic resonance; (iii) NO (nitrites and nitrates) production by Griess reaction; (iv) inflammation by ELISA assay; and (v) calcium signaling by confocal microscopy. The present study characterizes the in vitro model mimicking endothelial dysfunction in PH and indicates that, under such pathological conditions, oxidative stress and inflammation are increased along with calcium signaling alterations, as compared to the physiological conditions. Human exposure to carbon black NPs could produce greater deleterious effects in vulnerable patients suffering from cardiovascular diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Carbon black nanoparticles; Cyclic stretch; Endothelial dysfunction; Human endothelial cells; Hypoxia

Mesh:

Substances:

Year:  2021        PMID: 34524626     DOI: 10.1007/s12012-021-09679-6

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  50 in total

Review 1.  Pulmonary effects of inhaled ultrafine particles.

Authors:  G Oberdörster
Journal:  Int Arch Occup Environ Health       Date:  2001-01       Impact factor: 3.015

Review 2.  Cardiovascular effects of fine and ultrafine particles.

Authors:  Holger Schulz; Volker Harder; Angela Ibald-Mulli; Andrej Khandoga; Wolfgang Koenig; Fritz Krombach; Roman Radykewicz; Andreas Stampfl; Barbara Thorand; Annette Peters
Journal:  J Aerosol Med       Date:  2005

3.  Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells.

Authors:  Hideyuki Yamawaki; Naoharu Iwai
Journal:  Circ J       Date:  2006-01       Impact factor: 2.993

Review 4.  Review of the effects of manufactured nanoparticles on mammalian target organs.

Authors:  Tianshu Wu; Meng Tang
Journal:  J Appl Toxicol       Date:  2017-08-11       Impact factor: 3.446

Review 5.  Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells.

Authors:  Jonathan H Shannahan; Urmila P Kodavanti; Jared M Brown
Journal:  Inhal Toxicol       Date:  2012-04       Impact factor: 2.724

6.  Pulmonary exposure to carbon black nanoparticles and vascular effects.

Authors:  Lise K Vesterdal; Janne K Folkmann; Nicklas R Jacobsen; Majid Sheykhzade; Håkan Wallin; Steffen Loft; Peter Møller
Journal:  Part Fibre Toxicol       Date:  2010-11-05       Impact factor: 9.400

Review 7.  A work group report on ultrafine particles (American Academy of Allergy, Asthma & Immunology): Why ambient ultrafine and engineered nanoparticles should receive special attention for possible adverse health outcomes in human subjects.

Authors:  Ning Li; Steve Georas; Neil Alexis; Patricia Fritz; Tian Xia; Marc A Williams; Elliott Horner; Andre Nel
Journal:  J Allergy Clin Immunol       Date:  2016-04-06       Impact factor: 10.793

Review 8.  Systemic and cardiovascular effects of airway injury and inflammation: ultrafine particle exposure in humans.

Authors:  M W Frampton
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

9.  Early pulmonary response is critical for extra-pulmonary carbon nanoparticle mediated effects: comparison of inhalation versus intra-arterial infusion exposures in mice.

Authors:  Koustav Ganguly; Dariusch Ettehadieh; Swapna Upadhyay; Shinji Takenaka; Thure Adler; Erwin Karg; Fritz Krombach; Wolfgang G Kreyling; Holger Schulz; Otmar Schmid; Tobias Stoeger
Journal:  Part Fibre Toxicol       Date:  2017-06-20       Impact factor: 9.400

10.  Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.

Authors:  Mark R Miller; Jennifer B Raftis; Jeremy P Langrish; Steven G McLean; Pawitrabhorn Samutrtai; Shea P Connell; Simon Wilson; Alex T Vesey; Paul H B Fokkens; A John F Boere; Petra Krystek; Colin J Campbell; Patrick W F Hadoke; Ken Donaldson; Flemming R Cassee; David E Newby; Rodger Duffin; Nicholas L Mills
Journal:  ACS Nano       Date:  2017-04-26       Impact factor: 15.881

View more
  2 in total

1.  NiONP-Induced Oxidative Stress and Mitochondrial Impairment in an In Vitro Pulmonary Vascular Cell Model Mimicking Endothelial Dysfunction.

Authors:  Ophélie Germande; Thomas Ducret; Jean-Francois Quignard; Juliette Deweirdt; Véronique Freund-Michel; Marie-Hélène Errera; Guillaume Cardouat; Pierre Vacher; Bernard Muller; Patrick Berger; Christelle Guibert; Magalie Baudrimont; Isabelle Baudrimont
Journal:  Antioxidants (Basel)       Date:  2022-04-26

Review 2.  Mechanosensitivity in Pulmonary Circulation: Pathophysiological Relevance of Stretch-Activated Channels in Pulmonary Hypertension.

Authors:  Solène Barbeau; Guillaume Gilbert; Guillaume Cardouat; Isabelle Baudrimont; Véronique Freund-Michel; Christelle Guibert; Roger Marthan; Pierre Vacher; Jean-François Quignard; Thomas Ducret
Journal:  Biomolecules       Date:  2021-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.